0 results for 'Cohen, Milstein, Sellers & Toll'
Are 'Forever Chemicals' the Next Opioids?
Plaintiffs and defense firms alike are bracing for a new wave of environmental litigation centering on "forever chemicals," after the EPA has signaled to set new regulatory standards classifying these substances as hazardous under CERCLA, commonly known as "Superfund."Corporate Counsel Announces Its 2022 Women, Influence and Power in Law Awards
These outstanding women will be recognized at an awards dinner on Oct. 18 as part of our Women, Influence & Power in Law Conference in Washington, D.C.South Florida Suit Claims Water Expert Was Fired for Raising Concerns About Contamination
This lawsuit was surfaced on Law.com Radar. Read the complaint here.The 2022 Elite Trial Lawyers Awards—Highlights in Pictures
The 2022 Elite Trial Lawyers Awards honored excellent legal work in 23 practice areas as well as Elite Women of the Plaintiffs Bar and Rising Stars.Celebrating Excellence at the 2022 Elite Trial Lawyers Awards
The 2022 ETL award ceremony in New York honored outstanding plaintiffs work in various areas of litigation as well as law firm diversity efforts and attorney lifetime achievements.View more book results for the query "Cohen, Milstein, Sellers & Toll"
A Two-Week Haul of Litigator of the Week Runners-Up and Shout Outs
The runners-up this week are headed up by defense teams that represented the five remaining five chicken industry executives who went to trial for a third time on criminal antitrust charges in federal court in Denver.Brooklyn U.S. Attorney Intervenes in False Claims Act Suit Against Dialysis Company
The False Claims Act suit alleges that the defendants billed federal programs including Medicare and Medicaid for the cost of procedures, some of which were "risky and often unnecessary."Mental Health Improves for Women and Minority Lawyers: The Morning Minute
Want to get this daily news briefing by email? Here's the sign-up. WHAT WE'RE WATCHING OFFICE SPACE VS. HEADSPACE - Law firms are taking…Seitz: 'Context' of FDA Ratings Key in Medical Device Company's Derivative Case
The complaint, defense counsel argued, failed to show directors exhibited the state of mind needed for shareholders to proceed with their breach of fiduciary duty and related insider trading claims.Who Got the Work?℠: Samsung's Consumer Class Action Defense Counsel and More
Welcome to "Who Got the Work?℠," a weekly column that highlights the law firms and lawyers around the country who are being brought in to handle…State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now